patientportal.aegislabs.com | Aegis COVID-19 Testing Portal
Aegis TAT is assessed from sample receipt to test report dissemination. It excludes travel time to the lab. Aegis works with all collecting partners to maximize overnight shipping to the lab. Weekend shipping schedules may affect the duration between collection and the final Aegis report.
Please visit patientportal.aegislabs.com for updates
After receiving the sample and starting testing, the gateway will show that the sample was received and testing is underway. After testing, results will be available on the site. You will also be notified by email when your results are available.
Millions of people have been sickened by SARS-CoV-2 during the last year. Despite major advances in the understanding of the virus that causes COVID-19, healthcare providers, epidemiologists, virologists, and laboratory scientists have long struggled to restrict the virus’ transmission and treat people infected.
We’ve learned recently that the SARS-CoV-2 virus, like many respiratory infections before it, has mutated, potentially increasing infectivity and sickness. Due to their increased transmissibility, COVID-19 genetic variants like B.1.1.7 and 501Y.V2 have attracted the public’s and medical professionals’ attention. Concerns have also been raised about the ability of existing testing procedures to detect these novel genetic variations.
Aegis Sciences Corporation uses the TaqPathTM COVID-19 Combo Kit from Thermo Fisher Scientific. This approach investigates three genomic targets specific to SARS-CoV-2. Current COVID variants should not affect the TaqPath COVID-19 Combo Kit, the FDA says (i.e. B.1.17). Recent research shows that the TaqPath kit does not cause false-negative findings when testing COVID variants. 1,2 These novel mutant strains may affect testing methods that do not use 3 gene targets.
Aegis Sciences Corporation will continue to produce highly specific diagnostic test findings in a clinically relevant time frame, as it has done for over 3 million tests. Throughout the Pandemic, our team of clinicians and laboratory experts will continue to follow the scientific literature and clinical testing guidelines. Our objective is to assist clinicians to make better decisions by providing fast, accurate, and technically superior results.
An introduction to Aegis Sciences
An American laboratory sciences company founded in 1990, Aegis Sciences Corporation provides scientific testing and consulting services to clients including healthcare providers, pharmaceutical companies, professional and amateur sports organizations, leading college and university athletic programs, Fortune 500 companies, and government agencies. Visit http://www.aegislabs.com/ for additional details.
the Office of the Director, National Institutes of Health, Department of Health and Human Services, under Contract No.
The NIH Rapid Acceleration of Diagnostics (RADxSM) initiative is helping Aegis test 75N92020C00022.
When it comes to Walgreens
Walgreens (www.walgreens.com) is a global leader in retail and wholesale pharmacy. Walgreens, America’s favorite pharmacy, health, and beauty chain, exists to promote the health and wellness of all Americans. Every day, more than 8 million people rely on Walgreens for their health needs. Walgreens pharmacists provide a wide range of pharmacy and healthcare services in the US healthcare system. Walgreens delivers a true omnichannel experience, combining physical and digital platforms with cutting-edge technology to deliver high-quality products and services in local communities nationwide.
Read more: How COVID-19 Can Affect Your Heart?